2020
DOI: 10.1177/0300060520945506
View full text |Buy / Rent full text
|
Sign up to set email alerts
|

Abstract: Objective Thoracic endovascular aortic repair (TEVAR) is considered the mini-invasive treatment of choice for patients with Stanford type B aortic dissection (TBAD). This study aimed to investigate the clinical outcomes and quality of life (QoL) in patients with acute and subacute TBAD after TEVAR. Methods From January 2014 until July 2016, 22 acute patients (Group A) and 18 subacute patients received TEVAR (Group B), and 13 patients were managed non-operatively (Group C). The Medical Outcomes Study Short Form… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 13 publications
(16 reference statements)
0
4
0
Order By: Relevance
“…The overall survival rates for acute un-TBAD at 1 year and 3 years were reported (96.8%±3.1% and 90.4%±9.5%, respectively). Bi et al [11] also published overall survival rates at 3-year post-TEVAR and found 95.5% for acute (<15 days) and 100% for subacute (15-92 days) TBAD. The study included a total of 53 acute and subacute TBAD patients randomized into 3 groups (22 acute TBAD + TEVAR; 18 subacute TBAD + TEVAR; 13 TBAD + non-operative treatment).…”
Section: All-cause Mortalitymentioning
confidence: 97%
See 1 more Smart Citation
“…The overall survival rates for acute un-TBAD at 1 year and 3 years were reported (96.8%±3.1% and 90.4%±9.5%, respectively). Bi et al [11] also published overall survival rates at 3-year post-TEVAR and found 95.5% for acute (<15 days) and 100% for subacute (15-92 days) TBAD. The study included a total of 53 acute and subacute TBAD patients randomized into 3 groups (22 acute TBAD + TEVAR; 18 subacute TBAD + TEVAR; 13 TBAD + non-operative treatment).…”
Section: All-cause Mortalitymentioning
confidence: 97%
“…Mid-and long-term outcomes of thoracic endovascular aortic repair in acute and subacute uncomplicated type B aortic dissection Matti Jubouri 1 *, Mohammed Al-Tawil 2 *, Ho Cheung Anthony Yip 3 , Ali Bashir 4 , Sven ZCP Tan 5 , Mohamad Bashir MD PhD MRCS 6 , Richard Anderson BSc MBBS MD 7 , Damian Bailey PhD FRSC FPVRI FACSM FTPS 8 , Christoph A. Nienaber MD PhD MRCP 9 , Joseph S. Coselli MD 10,11,12 , Ian Williams MD FRCS 13…”
mentioning
confidence: 99%
“…The overall survival rates for acute un‐TBAD at 1 and 3 years were reported (96.8 ± 3.1% and 90.4 ± 9.5%, respectively). Bi et al 11 also published overall survival rates at 3‐year post‐TEVAR and found 95.5% for acute (<15 days) and 100% for subacute (15–92 days) TBAD. The study included a total of 53 acute and subacute TBAD patients randomized into three groups (22 acute TBAD + TEVAR; 18 subacute TBAD + TEVAR; 13 TBAD + nonoperative treatment).…”
Section: Late Outcomes (>30 Days)mentioning
confidence: 98%
“…The SF-36 questionnaire has been widely used to evaluate the quality of life after thoracic aortic surgery [14,15] , including patients with acute Type A AD after aortic replacement [16] , patients with AD after TEVAR [17] and patients with abdominal aortic aneurysm repair [18] . Therefore, the questionnaire is practical and applicable to the study population.…”
Section: The Current Qol B Ad Survivors In Zunyi Chinamentioning
confidence: 99%